Overview
Congenital primary lymphedema without systemic or visceral involvement is a rare genetic condition characterized by chronic swelling (lymphedema) that is present at birth or develops shortly thereafter, resulting from malformation or dysfunction of the lymphatic system. Unlike some other forms of primary lymphedema, this condition does not affect internal organs or other body systems — the lymphedema is confined to the extremities, most commonly the lower limbs. The condition is also historically referred to as Milroy disease or Nonne-Milroy lymphedema when it presents as a congenital-onset hereditary form, though the Orphanet classification (ORPHA:2416) encompasses congenital primary lymphedema presentations without visceral or systemic complications. The lymphatic vessels in affected individuals are underdeveloped or functionally impaired, leading to an accumulation of protein-rich fluid in the tissues. Key clinical features include bilateral or unilateral swelling of the legs and feet that is typically non-pitting and progressive. Over time, the skin may become thickened and fibrotic. Recurrent skin infections (cellulitis) are a common complication due to impaired lymphatic drainage and local immune function. Some patients may also develop upslanting toenails or prominent leg veins. There is currently no cure for congenital primary lymphedema. Management focuses on reducing swelling and preventing complications through conservative measures such as complex decongestive therapy (CDT), which includes manual lymphatic drainage, compression bandaging, skin care, and exercise. Compression garments are used for long-term maintenance. Prompt treatment of skin infections with antibiotics is essential. In severe or refractory cases, surgical options such as lymphovenous anastomosis or debulking procedures may be considered. Genetic counseling is recommended for affected families.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital primary lymphedema without systemic or visceral involvement.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital primary lymphedema without systemic or visceral involvement at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Congenital primary lymphedema without systemic or visceral involvement.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital primary lymphedema without systemic or visceral involvement.
Community
No community posts yet. Be the first to share your experience with Congenital primary lymphedema without systemic or visceral involvement.
Start the conversation →Latest news about Congenital primary lymphedema without systemic or visceral involvement
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital primary lymphedema without systemic or visceral involvement
What is Congenital primary lymphedema without systemic or visceral involvement?
Congenital primary lymphedema without systemic or visceral involvement is a rare genetic condition characterized by chronic swelling (lymphedema) that is present at birth or develops shortly thereafter, resulting from malformation or dysfunction of the lymphatic system. Unlike some other forms of primary lymphedema, this condition does not affect internal organs or other body systems — the lymphedema is confined to the extremities, most commonly the lower limbs. The condition is also historically referred to as Milroy disease or Nonne-Milroy lymphedema when it presents as a congenital-onset he
How is Congenital primary lymphedema without systemic or visceral involvement inherited?
Congenital primary lymphedema without systemic or visceral involvement follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital primary lymphedema without systemic or visceral involvement typically begin?
Typical onset of Congenital primary lymphedema without systemic or visceral involvement is neonatal. Age of onset can vary across affected individuals.